Banyan Capital Management’s Amgen AMGN Stock Holding History

Banyan Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-86	Closed	-$16K	–	22
2018 Q4	$16K	Buy	+86	New	+$16.8K	0.02%	35

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Banyan Capital Management's AMGN Position: Q1 2019 in Review

Banyan Capital Management sold out of Amgen (AMGN) in Q1 2019, closing a stake of 86 shares — an estimated $16K sold.

Banyan Capital Management first reported a position in AMGN in Q4 2018 and held it in 1 quarter. The position peaked at $16K in Q4 2018. 1,887 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.

Banyan Capital Management reported no remaining Amgen position as of Q1 2019 after selling out during the quarter.
Banyan Capital Management sold 86 Amgen shares in Q1 2019, an estimated $16K.
Banyan Capital Management first reported a position in Amgen in Q4 2018 and held it in 1 quarter.
Banyan Capital Management's Amgen position peaked at $16K in Q4 2018.
1,887 funds tracked by Wall St. Rank held Amgen as of Q1 2019.

Based on Banyan Capital Management's 13F filing for Q1 2019, filed 9 May 2019.